29 April 2021
Viscgo secures investment to launch its innovative device to improve quality of life for people with swallowing difficulties
MANCHESTER, UK: 28th April 2021 -Viscgo Limited, a ground-breaking new medical device company, today announced receipt of £265,000 investment to launch its first-generation device to improve the management of dysphagia (swallowing difficulties). The funding came from a...
13 April 2021
Maxwellia on course to launch self-care alternatives following £3.2m funding round
A Cheshire business that aims to transform the UK’s self-care market has secured a £3.2m investment in a funding round led by Manchester-based Praetura Ventures. Maxwellia, which is based at Alderley Park, aims to give people easier and faster access to the...
12 April 2021
Deals agreed as Infex's resistance bypass drug program heads for clinic
Alderley Park, Cheshire Infex Therapeutics has appointed Pharmaron to help progress its MET-X program which targets urinary tract infections caused by WHO critical-priority resistant Gram-negative bacteria. Pharmaron will manufacture the patented molecule at its plant in...
7 April 2021
Panthera Biopartners appoints corporate financier Christopher Steed as a non-executive director to continue UK and overseas expansion
Independent clinical trial site management organisation (SMO), Panthera Biopartners, has appointed M&A and fundraisings adviser Chris Steed as a non-executive director. Chris has over 25 years’ experience as a corporate financier, working at Arthur Andersen, Deloitte...
1 April 2021
Infex focuses on pandemic preparedness with Covid patent
Infex Therapeutics has filed for a UK patent for a novel therapy designed to tackle all coronavirus strains. The COV-X program targets a protein which is essential for viral replication across a broad spectrum of related coronaviruses, including SARS-CoV-1, MERS-CoV and...
26 March 2021
Healum closes investment round to develop UKRI funded AI powered patient management system for people with long term conditions
MANCHESTER, UK, 25th March 2021 - Healum, a leading digital health company, known for developing a ground-breaking AI powered patient management system to improve health outcomes and quality of life for people with long term conditions, has raised funding from NPIF – Maven...
25 March 2021
Panthera Biopartners commences a Ph 3 trial for AstraZeneca’s monoclonal antibody combination to reduce the effects of COVID-19
Panthera is running a Ph 3 trial for AstraZeneca’s monoclonal antibody combination to reduce the effects of COVID-19 in patients with the virus from its North Manchester site … Panthera is running a double-blind, placebo-controlled trial of AstraZeneca’s AZD7422...
8 March 2021
UK healthtech startup Rinicare appoints leading AI and machine learning specialist as Chief Technology and Data Officer
Manchester-based clinician-led digital health company, Rinicare, has appointed AI and machine learning specialist Miguel Mendao as its Chief Technology and Data Officer to help further develop its impressive portfolio of AI-driven technologies for healthcare. Rinicare Managing...
1 March 2021
Panthera further strengthens its oncology clinical trials team with the appointment of Matt Cooper as General Manager Oncology
Panthera Biopartners, an independent SMO (Site Management Organisation), has appointed Matt Cooper as General Manager, Oncology. Matt has extensive experience in the recruitment and running of clinical trials in oncology. Until recently, Matt has been Chief Operating Officer of...
25 February 2021
Biorelate signs multi-year deal with e-therapeutics
Biorelate has announced a new 3 year contract with e-therapeutics PLC for Galactic Data. After 2 successful years of collaboration, Biorelate will continue to provide auto-curated cause-and-effect data to fuel e-therapeutics’ data-driven discovery platform. Jonny Wray (CTO...